Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -99.35% is 14% below its 5-year average of -86.82%, near the high end of its 5-year range (-234.02%–-48.70%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.12% above its 12-month average of -99.47%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -99.35%.
RETURN ON INVESTED CAPITAL (ROIC)
-99.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-99.47%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-122.26%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-86.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+0.12%
CURRENT VS 3Y AVG
+18.74%
CURRENT VS 5Y AVG
-14.43%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-29.89%
median of 511 covered companies
CURRENT VS SECTOR MEDIAN
-232.38%
vs the sector median at left
Inhibrx Biosciences Inc.
Market Cap
$1.40B
Return on Invested Capital (ROIC)
-99.35%
TTM Avg
-99.47%
3Y Avg
-122.26%
5Y Avg
-86.82%
Market Cap
$1.38B
Return on Invested Capital (ROIC)
-38.09%
TTM Avg
-38.09%
3Y Avg
-38.09%
5Y Avg
-38.09%
Market Cap
$1.36B
Return on Invested Capital (ROIC)
-40.47%
TTM Avg
-45.26%
3Y Avg
-38.46%
5Y Avg
-34.74%
Market Cap
$1.29B
Return on Invested Capital (ROIC)
-57.11%
TTM Avg
-57.11%
3Y Avg
-57.11%
5Y Avg
-57.11%
Market Cap
$1.43B
Return on Invested Capital (ROIC)
47.55%
TTM Avg
-5.71%
3Y Avg
-17.68%
5Y Avg
-14.30%
Market Cap
$1.33B
Return on Invested Capital (ROIC)
-47.96%
TTM Avg
-47.20%
3Y Avg
-41.20%
5Y Avg
-37.18%
Market Cap
$1.40B
Return on Invested Capital (ROIC)
-24.52%
TTM Avg
-24.52%
3Y Avg
-24.52%
5Y Avg
-24.52%
Market Cap
$1.47B
Return on Invested Capital (ROIC)
16.83%
TTM Avg
6.43%
3Y Avg
6.32%
5Y Avg
5.53%
Market Cap
$1.48B
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Inhibrx Biosciences Inc. (INBX) | $1.40B | -99.35% | -99.47% | -122.26% | -86.82% |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.38B | -38.09% | -38.09% | -38.09% | -38.09% |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.36B | -40.47% | -45.26% | -38.46% | -34.74% |
| Kardigan, Inc. (KARD)vs › | $1.29B | -57.11% | -57.11% | -57.11% | -57.11% |
| AnaptysBio, Inc. (ANAB)vs › | $1.43B | 47.55% | -5.71% | -17.68% | -14.30% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $1.33B | -47.96% | -47.20% | -41.20% | -37.18% |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.40B | -24.52% | -24.52% | -24.52% | -24.52% |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.47B | 16.83% | 6.43% | 6.32% | 5.53% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.48B | N/A | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.51B | -19.87% | -24.87% | -20.19% | -15.68% |
ROIC
-99.3%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -99.35% |
| 2026-03-31 | -76.97% |
| 2025-12-31 | -117.41% |
| 2025-09-30 | -107.16% |
| 2025-06-30 | -96.44% |
| 2025-03-31 | -151.02% |
| 2024-12-31 | -234.02% |
| 2024-09-30 | -207.21% |
| 2024-06-30 | -168.14% |
| 2024-03-31 | -113.13% |
| 2023-12-31 | -87.14% |
| 2023-09-30 | -49.39% |
| 2023-06-30 | -81.94% |
| 2023-03-31 | -64.52% |
| 2022-12-31 | -48.70% |
| 2022-09-30 | -80.05% |
| 2022-06-30 | -59.64% |
| 2022-03-31 | -60.97% |
| 2021-12-31 | -59.06% |
| 2021-09-30 | -70.29% |
| 2021-06-30 | -58.31% |
| 2021-03-31 | -69.65% |
| 2020-12-31 | -59.24% |
| 2020-09-30 | -57.84% |
| 2019-12-31 | -386.82% |
